Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: Antitumor activity in a phase II trial and interactions in vitro Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Interferon-alpha
  • Isotretinoin
  • Kidney Neoplasms

abstract

  • IFN and CRA showed antitumor activity in patients with advanced RCC, and the proportion and nature of response suggested CRA added therapeutic benefit to IFN. A phase III randomized trial of IFN plus CRA versus IFN alone and a phase II trial of single-agent CRA have been initiated.

publication date

  • August 1995

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 7636535

Additional Document Info

start page

  • 1950

end page

  • 7

volume

  • 13

number

  • 8